AMRI

Join our mailing list
Name		Email

Overview

Management Team

Directions

Global Facilities

Overview

Drug Discovery

Development

cGMP Manufacturing

Aseptic Fill & Finish

Project Management

Overview

Bacterial Infection

Irritable Bowel Syndrome

Obesity

Oncology

CNS Disorders

Natural Product Libraries

Overview

Corporate Governance

Stock Quote

Stock Chart

Analyst Coverage

Annual Reports

SEC Filings

Upcoming Events

News and Event Alerts

Webcasts

Contact Information

News Releases

Events

Annual Reports

Brochures

Technical Reports

Patent Publications

Job Opportunities

FAQs



			Clinical Drug Products



			Generic Drugs

AMRI's New Subsidiary, Hyaluron: www.Hyaluron.com

Sunday, August 1, 2010

07.28.2010
AMRI to Announce Second Quarter 2010 Results

07.21.2010
AMRI Announces Phase I Study of Novel Drug for Obesity Treatment

06.21.2010
AMRI Announces $10 Million Share Repurchase Program

09.14.2010
Pharma ChemOutsourcing
Ocean Place Resort, Long Branch, NJ

10.5.2010
CPhI
Paris-Nord Villepinte, Paris, France

10.19.2010
AusBiotech
Melbourne Convention & Exhib Centre, Melbourne, Australia